Compare VYGR & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | ELMD |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 232.0M |
| IPO Year | 2015 | 2010 |
| Metric | VYGR | ELMD |
|---|---|---|
| Price | $4.00 | $28.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $17.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 467.1K | 46.8K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.89 |
| EPS | N/A | ★ 0.94 |
| Revenue | $31,316,000.00 | ★ $66,218,999.00 |
| Revenue This Year | N/A | $14.63 |
| Revenue Next Year | $71.78 | $11.54 |
| P/E Ratio | ★ N/A | $31.83 |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $2.65 | $17.73 |
| 52 Week High | $6.37 | $35.56 |
| Indicator | VYGR | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 59.36 |
| Support Level | $4.24 | $29.45 |
| Resistance Level | $4.58 | $30.49 |
| Average True Range (ATR) | 0.24 | 0.97 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 31.36 | 58.07 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.